[Anticancer properties of flagellate protozoan Trypanosoma cruzi Chagas, 1909]

V D Kallinikova1, P V Matekin, T A Ogloblina

  • 1Moscow State University, Vorob'evy gory, Moscow, 119899 Russia.

Izvestiia Akademii Nauk. Seriia Biologicheskaia
|July 4, 2001
PubMed

Insights

Trypanosoma cruzi exhibits anticancer activity, inhibiting tumor growth and selectively damaging cancer cells. This parasite shows promise for cancer prevention and treatment through its unique tumortropism.

Area of Science:

  • Parasitology
  • Oncology
  • Immunology

Context:

  • Trypanosoma cruzi, a protozoan parasite, has demonstrated significant anticancer properties.
  • Seven strains of T. cruzi were evaluated for their efficacy against sarcoma-180.
  • Parasite tumortropism, or preference for cancer cells, was a key observation.

Purpose:

  • To confirm and characterize the anticancer activity of Trypanosoma cruzi.
  • To investigate the mechanism and nature of the anticancer agent produced by T. cruzi.
  • To explore the potential of T. cruzi in cancer prevention and treatment.

Summary:

  • Virulent T. cruzi strains inhibited sarcoma-180 growth by 1.5-22.0 times.
  • T. cruzi parasites demonstrated tumortropism, preferentially developing in cancer cells.
  • T. cruzi cultures produced an anticancer agent selectively damaging human cancer cells in vitro.
  • Both long-term anticancer and potential cancer-preventing effects were observed.

Impact:

  • T. cruzi presents a novel avenue for cancer therapy development.
  • Understanding T. cruzi's anticancer mechanisms could lead to new drug targets.
  • The study suggests potential applications of T. cruzi in cancer prevention strategies.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...